CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 98 enrolled
Drug / intervention
Arm 1 stereotactic body radiation therapy +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00843726
NCT00843726Phase 2Completed
CompareCT.gov

A Phase II Randomized Study of 2 Stereotactic Body Radiation Therapy (SBRT) Regimens for Medically Inoperable Patients With Node Negative, Peripheral Non-Small Cell Lung Cancer

Roswell Park Cancer Institute·interventional·Posted Feb 13, 2009·Updated Jun 15, 2021

In Brief

A Phase 2 clinical trial evaluating Arm 1 stereotactic body radiation therapy and Arm II stereotactic body radiation therapy for Lung Cancer. Completed, enrolled 98 participants across 3 sites.

Detailed Summary

RATIONALE: Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. It is not yet known which regimen of radiation therapy is more effective in treating patients with non-small cell lung cancer. PURPOSE: This randomized phase II trial is studying the side effects of two radiation therapy regimens and to see how well they work in treating patients with stage I or stage II non-small cell lung cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 13, 2009
Enrollment StartSep 12, 2008
Primary CompletionMay 6, 2020
TodayJul 2, 2026
Enrollment to primary: 11.7 yearsPosted 17.4 years ago

Interventions

Arm 1 stereotactic body radiation therapyradiation

Patients undergo 1 high-dose fraction

Arm II stereotactic body radiation therapyradiation

Patients undergo 3 high-dose fractions